A carregar...
Development of (225)Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences
BACKGROUND: The development of radiopharmaceuticals containing 225Ac for targeted alpha therapy is an active area of academic and commercial research worldwide. OBJECTIVES: Despite promising results from recent clinical trials, 225Ac-radiopharmaceutical development still faces significant challenges...
Na minha lista:
| Publicado no: | Curr Radiopharm |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bentham Science Publishers
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249690/ https://ncbi.nlm.nih.gov/pubmed/29658444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874471011666180416161908 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|